Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
101 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Dystrophin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Dystrophin in these regions, from 2012 to 2022 (forecast).
United States Dystrophin market competition by top manufacturers/players, with Dystrophin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
DS-5141
Biostrophin
BMBD-001
NS-065
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Genetic Disorders
Musculoskeletal Disorders
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Dystrophin Market Report 2017
1 Dystrophin Overview
1.1 Product Overview and Scope of Dystrophin
1.2 Classification of Dystrophin by Product Category
1.2.1 United States Dystrophin Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Dystrophin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 DS-5141
1.2.4 Biostrophin
1.2.5 BMBD-001
1.2.6 NS-065
1.2.7 Others
1.3 United States Dystrophin Market by Application/End Users
1.3.1 United States Dystrophin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Genetic Disorders
1.3.3 Musculoskeletal Disorders
1.3.4 Others
1.4 United States Dystrophin Market by Region
1.4.1 United States Dystrophin Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Dystrophin Status and Prospect (2012-2022)
1.4.3 Southwest Dystrophin Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Dystrophin Status and Prospect (2012-2022)
1.4.5 New England Dystrophin Status and Prospect (2012-2022)
1.4.6 The South Dystrophin Status and Prospect (2012-2022)
1.4.7 The Midwest Dystrophin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Dystrophin (2012-2022)
1.5.1 United States Dystrophin Sales and Growth Rate (2012-2022)
1.5.2 United States Dystrophin Revenue and Growth Rate (2012-2022)
2 United States Dystrophin Market Competition by Players/Suppliers
2.1 United States Dystrophin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Dystrophin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Dystrophin Average Price by Players/Suppliers (2012-2017)
2.4 United States Dystrophin Market Competitive Situation and Trends
2.4.1 United States Dystrophin Market Concentration Rate
2.4.2 United States Dystrophin Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dystrophin Manufacturing Base Distribution, Sales Area, Product Type
3 United States Dystrophin Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Dystrophin Sales and Market Share by Region (2012-2017)
3.2 United States Dystrophin Revenue and Market Share by Region (2012-2017)
3.3 United States Dystrophin Price by Region (2012-2017)
4 United States Dystrophin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Dystrophin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Dystrophin Revenue and Market Share by Type (2012-2017)
4.3 United States Dystrophin Price by Type (2012-2017)
4.4 United States Dystrophin Sales Growth Rate by Type (2012-2017)
5 United States Dystrophin Sales (Volume) by Application (2012-2017)
5.1 United States Dystrophin Sales and Market Share by Application (2012-2017)
5.2 United States Dystrophin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Dystrophin Players/Suppliers Profiles and Sales Data
6.1 Asklepios BioPharmaceutical Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Dystrophin Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Asklepios BioPharmaceutical Inc Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 BioMarin Pharmaceutical Inc
6.2.2 Dystrophin Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 BioMarin Pharmaceutical Inc Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Daiichi Sankyo Company Ltd
6.3.2 Dystrophin Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Daiichi Sankyo Company Ltd Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Editas Medicine Inc
6.4.2 Dystrophin Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Editas Medicine Inc Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Genethon SA
6.5.2 Dystrophin Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Genethon SA Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Nippon Shinyaku Co Ltd
6.6.2 Dystrophin Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Nippon Shinyaku Co Ltd Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer Inc
6.7.2 Dystrophin Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Inc Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sarepta Therapeutics Inc
6.8.2 Dystrophin Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sarepta Therapeutics Inc Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 WAVE Life Sciences Ltd
6.9.2 Dystrophin Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 WAVE Life Sciences Ltd Dystrophin Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
7 Dystrophin Manufacturing Cost Analysis
7.1 Dystrophin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dystrophin
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Dystrophin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dystrophin Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Dystrophin Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Dystrophin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Dystrophin Sales Volume Forecast by Type (2017-2022)
11.3 United States Dystrophin Sales Volume Forecast by Application (2017-2022)
11.4 United States Dystrophin Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Dystrophin
Figure United States Dystrophin Market Size (K Pcs) by Type (2012-2022)
Figure United States Dystrophin Sales Volume Market Share by Type (Product Category) in 2016
Figure DS-5141 Product Picture
Figure Biostrophin Product Picture
Figure BMBD-001 Product Picture
Figure NS-065 Product Picture
Figure Others Product Picture
Figure United States Dystrophin Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Dystrophin by Application in 2016
Figure Genetic Disorders Examples
Table Key Downstream Customer in Genetic Disorders
Figure Musculoskeletal Disorders Examples
Table Key Downstream Customer in Musculoskeletal Disorders
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Dystrophin Market Size (Million USD) by Region (2012-2022)
Figure The West Dystrophin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Dystrophin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Dystrophin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Dystrophin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Dystrophin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Dystrophin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dystrophin Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Dystrophin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dystrophin Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Dystrophin Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Dystrophin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dystrophin Sales Share by Players/Suppliers
Figure 2017 United States Dystrophin Sales Share by Players/Suppliers
Figure United States Dystrophin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Dystrophin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Dystrophin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dystrophin Revenue Share by Players/Suppliers
Figure 2017 United States Dystrophin Revenue Share by Players/Suppliers
Table United States Market Dystrophin Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Dystrophin Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Dystrophin Market Share of Top 3 Players/Suppliers
Figure United States Dystrophin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dystrophin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dystrophin Product Category
Table United States Dystrophin Sales (K Pcs) by Region (2012-2017)
Table United States Dystrophin Sales Share by Region (2012-2017)
Figure United States Dystrophin Sales Share by Region (2012-2017)
Figure United States Dystrophin Sales Market Share by Region in 2016
Table United States Dystrophin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Dystrophin Revenue Share by Region (2012-2017)
Figure United States Dystrophin Revenue Market Share by Region (2012-2017)
Figure United States Dystrophin Revenue Market Share by Region in 2016
Table United States Dystrophin Price (USD/Pcs) by Region (2012-2017)
Table United States Dystrophin Sales (K Pcs) by Type (2012-2017)
Table United States Dystrophin Sales Share by Type (2012-2017)
Figure United States Dystrophin Sales Share by Type (2012-2017)
Figure United States Dystrophin Sales Market Share by Type in 2016
Table United States Dystrophin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Dystrophin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dystrophin by Type (2012-2017)
Figure Revenue Market Share of Dystrophin by Type in 2016
Table United States Dystrophin Price (USD/Pcs) by Types (2012-2017)
Figure United States Dystrophin Sales Growth Rate by Type (2012-2017)
Table United States Dystrophin Sales (K Pcs) by Application (2012-2017)
Table United States Dystrophin Sales Market Share by Application (2012-2017)
Figure United States Dystrophin Sales Market Share by Application (2012-2017)
Figure United States Dystrophin Sales Market Share by Application in 2016
Table United States Dystrophin Sales Growth Rate by Application (2012-2017)
Figure United States Dystrophin Sales Growth Rate by Application (2012-2017)
Table Asklepios BioPharmaceutical Inc Basic Information List
Table Asklepios BioPharmaceutical Inc Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Asklepios BioPharmaceutical Inc Dystrophin Sales Growth Rate (2012-2017)
Figure Asklepios BioPharmaceutical Inc Dystrophin Sales Market Share in United States (2012-2017)
Figure Asklepios BioPharmaceutical Inc Dystrophin Revenue Market Share in United States (2012-2017)
Table BioMarin Pharmaceutical Inc Basic Information List
Table BioMarin Pharmaceutical Inc Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioMarin Pharmaceutical Inc Dystrophin Sales Growth Rate (2012-2017)
Figure BioMarin Pharmaceutical Inc Dystrophin Sales Market Share in United States (2012-2017)
Figure BioMarin Pharmaceutical Inc Dystrophin Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Company Ltd Basic Information List
Table Daiichi Sankyo Company Ltd Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Company Ltd Dystrophin Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Company Ltd Dystrophin Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Company Ltd Dystrophin Revenue Market Share in United States (2012-2017)
Table Editas Medicine Inc Basic Information List
Table Editas Medicine Inc Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Editas Medicine Inc Dystrophin Sales Growth Rate (2012-2017)
Figure Editas Medicine Inc Dystrophin Sales Market Share in United States (2012-2017)
Figure Editas Medicine Inc Dystrophin Revenue Market Share in United States (2012-2017)
Table Genethon SA Basic Information List
Table Genethon SA Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genethon SA Dystrophin Sales Growth Rate (2012-2017)
Figure Genethon SA Dystrophin Sales Market Share in United States (2012-2017)
Figure Genethon SA Dystrophin Revenue Market Share in United States (2012-2017)
Table Nippon Shinyaku Co Ltd Basic Information List
Table Nippon Shinyaku Co Ltd Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Nippon Shinyaku Co Ltd Dystrophin Sales Growth Rate (2012-2017)
Figure Nippon Shinyaku Co Ltd Dystrophin Sales Market Share in United States (2012-2017)
Figure Nippon Shinyaku Co Ltd Dystrophin Revenue Market Share in United States (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Dystrophin Sales Growth Rate (2012-2017)
Figure Pfizer Inc Dystrophin Sales Market Share in United States (2012-2017)
Figure Pfizer Inc Dystrophin Revenue Market Share in United States (2012-2017)
Table Sarepta Therapeutics Inc Basic Information List
Table Sarepta Therapeutics Inc Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sarepta Therapeutics Inc Dystrophin Sales Growth Rate (2012-2017)
Figure Sarepta Therapeutics Inc Dystrophin Sales Market Share in United States (2012-2017)
Figure Sarepta Therapeutics Inc Dystrophin Revenue Market Share in United States (2012-2017)
Table WAVE Life Sciences Ltd Basic Information List
Table WAVE Life Sciences Ltd Dystrophin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure WAVE Life Sciences Ltd Dystrophin Sales Growth Rate (2012-2017)
Figure WAVE Life Sciences Ltd Dystrophin Sales Market Share in United States (2012-2017)
Figure WAVE Life Sciences Ltd Dystrophin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dystrophin
Figure Manufacturing Process Analysis of Dystrophin
Figure Dystrophin Industrial Chain Analysis
Table Raw Materials Sources of Dystrophin Major Players/Suppliers in 2016
Table Major Buyers of Dystrophin
Table Distributors/Traders List
Figure United States Dystrophin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Dystrophin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Dystrophin Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Dystrophin Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Dystrophin Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Dystrophin Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Dystrophin Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Dystrophin Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Dystrophin Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Dystrophin Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Dystrophin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dystrophin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dystrophin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
